Molina Healthcare (NYSE:MOH) had its target price reduced by research analysts at Morgan Stanley from $97.00 to $94.00 in a research report issued to clients and investors on Wednesday. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price target would suggest a potential upside of 13.54% from the company’s current price.

A number of other equities analysts have also recently commented on the stock. JPMorgan Chase & Co. raised shares of Molina Healthcare from a “neutral” rating to an “overweight” rating in a research note on Tuesday, January 16th. Leerink Swann lifted their price objective on shares of Molina Healthcare from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, January 9th. Goldman Sachs Group began coverage on shares of Molina Healthcare in a research note on Wednesday, January 3rd. They issued a “neutral” rating and a $83.00 price objective for the company. Zacks Investment Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $88.00 price objective for the company in a research note on Tuesday, January 2nd. Finally, Raymond James Financial reissued a “hold” rating on shares of Molina Healthcare in a research note on Friday, December 8th. Three equities research analysts have rated the stock with a sell rating, ten have issued a hold rating, four have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Hold” and an average price target of $71.21.

Shares of Molina Healthcare (NYSE MOH) traded up $0.36 during trading hours on Wednesday, hitting $82.79. 85,760 shares of the company’s stock were exchanged, compared to its average volume of 1,308,538. Molina Healthcare has a 1-year low of $42.56 and a 1-year high of $93.98. The stock has a market cap of $5,228.27, a PE ratio of -13.64, a P/E/G ratio of 1.02 and a beta of 1.10. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 1.06.

In other news, Director Garrey Carruthers sold 1,300 shares of the firm’s stock in a transaction dated Thursday, November 16th. The shares were sold at an average price of $75.66, for a total value of $98,358.00. Following the completion of the sale, the director now owns 7,016 shares in the company, valued at approximately $530,830.56. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director John C. Molina sold 5,385 shares of the firm’s stock in a transaction dated Friday, January 26th. The stock was sold at an average price of $92.88, for a total transaction of $500,158.80. Following the completion of the sale, the director now owns 414,151 shares of the company’s stock, valued at approximately $38,466,344.88. The disclosure for this sale can be found here. Insiders sold a total of 777,955 shares of company stock valued at $61,729,330 in the last 90 days. Company insiders own 6.20% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in MOH. Thrivent Financial For Lutherans lifted its holdings in Molina Healthcare by 6.3% during the 2nd quarter. Thrivent Financial For Lutherans now owns 8,580 shares of the company’s stock valued at $594,000 after buying an additional 510 shares in the last quarter. UBS Asset Management Americas Inc. lifted its holdings in Molina Healthcare by 7.6% during the 2nd quarter. UBS Asset Management Americas Inc. now owns 30,472 shares of the company’s stock valued at $2,108,000 after buying an additional 2,165 shares in the last quarter. Vanguard Group Inc. lifted its holdings in Molina Healthcare by 1.9% during the 2nd quarter. Vanguard Group Inc. now owns 3,619,435 shares of the company’s stock valued at $250,392,000 after buying an additional 66,206 shares in the last quarter. FMR LLC bought a new stake in Molina Healthcare during the 2nd quarter valued at about $9,420,000. Finally, California Public Employees Retirement System lifted its holdings in Molina Healthcare by 4.6% during the 2nd quarter. California Public Employees Retirement System now owns 70,300 shares of the company’s stock valued at $4,863,000 after buying an additional 3,100 shares in the last quarter. Institutional investors own 96.22% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Molina Healthcare (MOH) PT Lowered to $94.00 at Morgan Stanley” was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this news story on another website, it was stolen and reposted in violation of US and international copyright & trademark laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2018/02/07/molina-healthcare-moh-pt-lowered-to-94-00-at-morgan-stanley.html.

Molina Healthcare Company Profile

Molina Healthcare, Inc offers Medicaid-related solutions for low-income families and individuals, and assists government agencies in their administration of the Medicaid program. The Company operates through three segments: Health Plans, Molina Medicaid Solutions and Other, which includes its Pathways Health and Community Support LLC (Pathways) business.

Analyst Recommendations for Molina Healthcare (NYSE:MOH)

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.